在患有乳腺癌的患者中,ribociclib诱导的肺透
1Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
概括
利博西克利布是转移性乳腺癌的CDK4/6抑制剂,可能导致肺透. 一名患者在治疗期间出现了肺部问题,随着时间的推移,病情恶化.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 乳腺癌是全球女性的主要癌症.
- 循环素依赖性激酶4/6 (CDK) 抑制剂用于激素受体阳性,HER2阴性转移性乳腺癌.
- 不良事件在CDK4/6抑制剂之间有所不同.
研究的目的:
- 报告一个可能与利博西克利布治疗相关的肺透病例.
- 为了突出与CDK4/6抑制剂相关的罕见不良事件.
主要方法:
- 一个48岁的患有转移性乳腺癌的女性患者在Ribociclib的病例报告.
- 在例行随访期间检测到的肺透的监测.
- 排除传染性和其他间歇性肺部疾病.
主要成果:
- 在Ribociclib治疗期间,在右下肺叶中检测到肺透物.
- 透剂在继续使用利博西基利布时显示最小的增加.
- 纳兰乔药物不良反应概率尺度表明,利博西克利布和透物之间可能存在关系.
结论:
- 持续使用利博西克利布与增加肺透率有关.
- 肺部透物是对Ribociclib的可能不良药物反应.
- 这一案例强调了在接受CDK4/6抑制剂的患者中监测肺毒性的重要性.
相关概念视频
Pulmonary Embolism I: Introduction
7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Pulmonary Embolism III: Nursing Management
15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Pulmonary Tuberculosis IV
164
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
164
Pulmonary Tuberculosis I
268
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
268
Pulmonary Tuberculosis II
264
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
264


